Qiagen said this week that it has made a number of changes to its management, notably naming a new CEO.
According to the company, current CEO Metin Colpan has decided to step down as of Jan. 1, transitioning to a new role as senior technology advisor and member of the supervisory board. He will be replaced by CFO Peer Schatz, who will become Qiagen’s president and CEO.
Roland Sackers will take over as CFO.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
